MedPath

Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery

Phase 3
Completed
Conditions
Urinary Incontinence
Interventions
Procedure: Vattikuti Urology Institute radical prostatectomy
Procedure: Retzius sparing radical prostatectomy
Device: da Vinci Surgical System
Registration Number
NCT02352103
Lead Sponsor
Henry Ford Health System
Brief Summary

To assess and compare the short-term post-operative continence recovery rate in two cohorts of men undergoing Robot Assisted Radical Prostatectomy (RARP), each randomized to undergo RARP with Vattikuti Institute technique or Retzius sparing technique.

Detailed Description

Traditionally, RARP is performed using a trans-peritoneal technique that pass anteriorly to the bladder. This technique necessitates the dissection and/or manipulation of many structures, which might compromise post-operative urinary continence recovery. These structures include the pubo-prostatic ligament, Santorini plexus, neurovascular bundle, and veil of Aphrodite. Recently, a "Retzius-sparing" technique to perform RARP has beed described. This approach passes posteriorly to the bladder, through the space of Douglas, which should minimize the damaged to the aforementioned structure. Theoretically, the latter technique should improve post-operative urinary continence recovery. However, a randomized comparison between the "traditional" RARP and "Retzius-sparing" RARP is still lacking.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
120
Inclusion Criteria
  • All patients with newly diagnosed prostate cancer undergoing robotic-assisted radical prostatectomy at the Vattikuti Urology Institute (performed by single surgeon, MM) as the primary treatment modality
  • Be able to read and speak English and be able to provide written informed consent
Exclusion Criteria
  • patients with high risk prostate cancer,defined as a biopsy Gleason score ≥8 and/or a pre-operative prostate specific antigen value ≥20 ng/ml.
  • evidence of clinical nodal involvement (cN1) or metastatic disease (M1)
  • patients participating in a competing study
  • patients with pre-operative urinary incontinence.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment armda Vinci Surgical SystemRetzius sparing radical prostatectomy da Vinci Surgical System
Control armda Vinci Surgical SystemVattikuti Urology Institute radical prostatectomy da Vinci Surgical System
Control armVattikuti Urology Institute radical prostatectomyVattikuti Urology Institute radical prostatectomy da Vinci Surgical System
Treatment armRetzius sparing radical prostatectomyRetzius sparing radical prostatectomy da Vinci Surgical System
Primary Outcome Measures
NameTimeMethod
Urinary Continence RecoveryOne week after the removal of the suprapubic urinary catheter

24-hour pad weights

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Urinary Continence Recoverywithin 3 months from the intervention

0 pad per day

Number of Participants With Peri and Postoperative Complications1-year median follow up

Clavien-Dindo complications

Number of Participants Who Regained Potency Postoperatively (as Measured by Sexual Health Inventory for Men (SHIM) Score of 17 or Greater)1-year median follow up

SHIM ranges from 0-25 with higher scores indicating better sexual function; a score of \>=22 is normal and \>=17 is considered mild ED

Number of Participants Who Had Biochemical Recurrence (Post-operative Prostate-Specific Antigen (PSA) Value >=0.2 ng/ml)1-year median follow up

Patients without biochemical evidence of disease recurrence (i.e. postop PSA \>=0.2 ng/mL)

Post-operative Urinary Function and Urinary Function-related Quality of LifeWithin 3 months from the intervention

International Prostatic Symptom Score (continuous score from 0-35, higher scores indicating worse urinary function)

Trial Locations

Locations (2)

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Henry Ford West Bloomfield Hospital

🇺🇸

West Bloomfield, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath